[1]
S. Soloviov, I. Dzyublyk, O. Zaliska, and A. Sakhno, “Analytical justification of including the antiviral drug into treatment scheme for patients with suspected viral disease”, AMI, no. 4, pp. 18–26, Jan. 2020.